Start HRT perimenopause for heart health
However, HRT offers no cardioprotective benefit when introduced for symptomatic relief at 10 or 20 years after menopause, warned cardiovascular and hypertension expert Suzanne Oparil, professor of medicine at the University of Alabama.
Speaking to MO ahead of a keynote address to Baker IDI’s public health forum on female hormones and cardiovascular disease this week, Professor Oparil said anxiety about the risks associated with HRT peaked in the years following the 2002 Women’s Health Initiative study, which linked HRT to increased risk of breast cancer, blood clots and strokes. However, she said later analyses found the interpretation of the original findings was flawed.
“One of the major problems with this study is that the majority of women involved were very old at the time they were treated with hormones.